共 50 条
- [37] Does addition of sitagliptin to metformin monotherapy improve glycemic control in patients with type 2 diabetes mellitus? Commentary NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM, 2007, 3 (06): : 450 - 451
- [38] Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, in patients with type 2 diabetes mellitus inadequately controlled on glimepiride alone or on glimepiride and metformin DIABETES OBESITY & METABOLISM, 2007, 9 (05): : 733 - 745
- [40] Efficacy and Safety of Adding Sitagliptin in Patients with Type 2 Diabetes Mellitus with Inadequate Glycaemic Control in Metformin Monotherapy PROCEEDINGS OF 6TH INTERNATIONAL CONFERENCE ON INTERDISCIPLINARY MANAGEMENT OF DIABETES MELLITUS AND ITS COMPLICATIONS (INTERDIAB), 2020, : 26 - 33